PCA demonstrated that some specific inflammatory mediators (e.g., IL-6, CXCL10, GDF-15, GM-CSF, CCL2) were the strongest determinants of the variance apparent between COVID-19 patients (fig. Here, CXCL10 is linked to COVID-19.